Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Chuv Centre Hospitalier Universitaire Vaudois maintains a concentrated prosecution presence within the Biotechnology & Pharmaceuticals technology area. The portfolio currently shows 1 pending office action, which is being handled by a single examiner. This focus indicates a specific intersection with the patent office examination corps, as the organization is not currently managing multiple simultaneous reviews.
The 1 distinct examiner involved is BEANE, RANDALL L, who is also identified as the busiest examiner for the company. This individual is responsible for the 1 pending office action currently on record. All activity is localized within 1 distinct art unit, reflecting a consolidated examination path for the organization current filings.
For a practitioner, this data suggests a streamlined interaction with the patent office. Because there is only 1 distinct examiner, the outcome of the current prosecution efforts depends on the review process within that 1 distinct art unit. The focus on Biotechnology & Pharmaceuticals ensures that the 1 pending office action is being handled by a specialized group.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BEANE, RANDALL L | 1 | 32.9% | +36.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18258587 | PULSATIVE GNRH ADMINISTRATION FOR TREATING FOOD INTAKE RELATED DISORDERS | BEANE, RANDALL L | — |
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18258587 | PULSATIVE GNRH ADMINISTRATION FOR TREATING FOOD INTAKE RELATED DISORDERS | BEANE, RANDALL L | 1654 | §103DP | Final Rejection | — | Pending | Jun 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChuv Centre Hospitalier Universitaire Vaudois has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Randall L Beane has the most, with 1 of Chuv Centre Hospitalier Universitaire Vaudois's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
